TD Cowen reiterated a 'Buy' rating on Axon stock.
3 reports, 1 independent
Updated Aug 6
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen reiterated a 'Buy' rating on Axon stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nippon Television AX-ON
Nothing else this week.
-
TD Cowen
American investment bank
Related events
- TD Cowen issued a buy rating and price target for Evolv Technologies Holdings, Inc.
- TD Cowen maintained a Buy rating on Forgent on September 15, 2026.
- TD Cowen reiterated buy rating on Axis Capital, with coverage reported by Benzinga.
- Rating firms Raymond James Financial and TD Cowen provided reaffirmed buy ratings and price targets for a company listed on Nasdaq.
- TD Cowen upgraded Crescent Biopharma shares to 'strong-buy', while Wedbush reiterated 'outperform', and a CEO sold shares under a 10b5-1 plan.
Coverage
Newest first; wire copies grouped- StockStoryAxon (AXON) Stock Trades Up, Here Is Why Shares of self defense company AXON (NASDAQ:AXON) jumped 4% in the afternoon session after investment firm TD Cowen reiterated its 'Buy' rating and $925 price
- StockStoryAxon’s Q2 Earnings Call: Our Top 5 Analyst Questions Axon's second quarter drew strong positive market reaction, reflecting the company’s ongoing ability to exceed Wall Street’s expectations. Managem